References
- Burgdorf SK, Nielsen HJ, Rosenberg J. Immunotherapy in colorectal cancer. Scand J Gastroenterol 2009; 44: 261–8
- Khan MA, Smythe A, Globe J, Stoddard CJ, Ackroyd R. Randomized controlled trial of laparoscopic Nissen versus Lind fundoplication for gastro-oesophageal reflux disease. Scand J Gastroenterol 2009; 44: 269–75
- Håkanson BS, Berggren P, Granqvist S, Ljungqvist O, Thorell A. Comparison of wireless 48-h (Bravo) versus traditional ambulatory 24-h esophageal pH monitoring. Scand J Gastroenterol 2009; 44: 276–83
- Høie O, Stallemo A, Matre J, Stokkeland M. Effect of oral lansoprazole on intragastric pH after endoscopic treatment for bleeding peptic ulcer. Scand J Gastroenterol 2009; 44: 284–8
- Kocsis AK, Kiss ZF, Tiszlavicz L, Tiszlavicz Z, Mandi Y. Potential role of human beta-defensin 1 in Helicobacter pylori-induced gastritis. Scand J Gastroenterol 2009; 44: 289–95
- Arisawa T, Tahara T, Shibata T, Nagasaka M, Nakamura M, Kamiya Y, et al. Association between promoter polymorphisms of nuclear factor-erythroid 2-related factor 2 gene and peptic ulcer diseases. Scand J Gastroenterol 2009; 44: 296–300
- Chitkara DK, Talley NJ, Schleck C, Zinsmeister AR, Shah ND, Locke GR 3rd. Recollection of childhood abdominal pain in adults with functional gastrointestinal disorders. Scand J Gastroenterol 2009; 44: 301–7
- Morken MH, Lind RA, Valeur J, Wilhelmsen I, Berstad A. Subjective health complaints and quality of life in patients with irritable bowel syndrome following Giardia lamblia infection: a case control study. Scand J Gastroenterol 2009; 44: 308–13
- Bremholm L, Hornum M, Henriksen BM, Larsen S, Holst JJ. Glucagon-like peptide-2 increases mesenteric blood flow in humans. Scand J Gastroenterol 2009; 44: 314–19
- Trecca A, Gaj F, Gagliardi G, Calcaterra R, Battista S, Silano M. Role of magnified ileoscopy in the diagnosis of cases of coeliac disease with predominant abdominal symptoms. Scand J Gastroenterol 2009; 44: 320–4
- Banerjee D, Deb R, Dar L, Mirdha BR, Pati SK, Thareja S, et al. High frequency of parasitic and viral stool pathogens in patients with active ulcerative colitis: report from a tropical country. Scand J Gastroenterol 2009; 44: 325–31
- Fukumoto A, Tanaka S, Imagawa H, Shishido T, Oka S, Yoshida S, et al. Usefulness and limitations of transabdominal ultrasonography for detecting small-bowel tumors. Scand J Gastroenterol 2009; 44: 332–8
- Persson C, Engstrand L, Nyren O, Hansson LE, Enroth H, Ekstrom AM, et al. Interleukin 1-beta gene polymorphisms and risk of gastric cancer in Sweden. Scand J Gastroenterol 2009; 44: 339–45
- Kim Hj, Kim JH, Choi JH, Yim HJ, Yeon JE, Park JJ, et al. The value of the model for end-stage liver disease for disease for predicting survival in hepatocellular carcinoma patients treated with transarterial chemoembolisation. Scand J Gastroenterol 2009; 44: 346–57
- Nan YM, Fu N, Wu WJ, Liang BL, Wang RQ, Zhao SX, et al. Rosiglitazone prevents nutritional fibrosis and steatohepatitis in mice. Scand J Gastroenterol 2009; 44: 358–65
- Ekstedt M, Franzen LE, Holmqvist M, Bendtsen P, Mathiesen UL, Bodemar G, et al. Alcohol consumption is associated with progression of hepatic fibrosis in non-alcoholic fatty liver disease. Scand J Gastroenterol 2009; 44: 366–74
- Chen H, Li X, Ge Z. Comparative study on two colonic bowel preparations for patients with chronic constipation. Scand J Gastroenterol 2009; 44: 375–89
- Velden AV, Wit ND, Quartero AO, Grobbee DE, Numans ME. GORD patients on chronic acid suppressive medication: a population-average psychological state. Scand J Gastroenterol 2009; 44: 380–2